'What You're Seeing Here Is Pure Censorship': What We Heard This Week

"What you're seeing here is pure censorship." -- Steven Kahn, MBChB, editor-in-chief of Diabetes Care, after American Diabetes Association (ADA) leadership blocked a collection of editorials discussing researchers' removal from the annual ADA meeting. "We're not going to pay for healthcare for dead people." -- CMS Administrator Mehmet Oz, MD, MBA, explaining tighter scrutiny on Medicaid claims as the administration froze over $1 billion in state funding over alleged fraud. "That's not protecting the American people." -- Melissa Loseke, DO, chief medical officer of the Re-New Institute in Omaha, Nebraska, and FDA advisory committee member, calling for stricter oversight after a patient took an unregulated peptide laced with MDMA. "The illness which is usually most feared by people is dementia." -- Gill Livingston, MD, of University College London, discussing updated World Health Organization guidelines to reduce cognitive decline and dementia risk. "The scary part is that it never plateaus." -- David Brown, MD, of Retina Consultants of Texas in Houston, commenting on a study showing continuous retinal nerve fiber thickening in geographic atrophy patients treated with complement inhibitors. "It can't continue indefinitely, and it's been really stressful." -- Nora Becker, MD, PhD, of the University of Michigan, on her university stepping in to pick up the tab for her study after federal grant funding stalled. "It's important to do research into the supplier." -- Michael DiStefano, PhD, of the University of Colorado Anschutz Medical Campus, on a secret shopper study that revealed safety violations at several GLP-1 drug compounding pharmacies. "There's a big gap in who's taking responsibility for these things." -- Raksha Jain, MD, of the University of Texas Southwestern Medical Center in Dallas, calling for reproductive healthcare to be integrated into routine cystic fibrosis management.